ClinicalTrials.gg
RecruitingNCT06329219Updated Mar 28, 2024

Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis

An interventional study of water-filtered Infrared-A radiation in Hand Osteoarthritis, sponsored by Charite University, Berlin, Germany. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-03-28.

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 131 studies in Osteoarthritis with a site in Germany — 12 open to participants now, 27 under way, 3 of them phase 3. Osteoarthritis · Germany.

Planned enrollment
67th of 98
70 · median 139
Started
2024
with 5 others
No phase
36 of 131
5 open now
Primary completion
2025-02
later than 5 of 26 live
Registered
121st of 131
by date
Lead sponsor
4 of 131
Charite University, Berlin, Germany

Among the 131 studies in Osteoarthritis with a site in Germany, this one is the 67th largest by planned enrollment of the 98 interventional ones that give a count, is one of 6 that started in 2024, is one of 36 with no phase, reaches primary completion later than 5 of the 26 other live ones, and was the 121st registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

12 of the 131 studies in Osteoarthritis with a site in Germany are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 131 studies in Osteoarthritis with a site in Germany, or all of them as a file.
02

Study summary

The aim of this clinical trial is to evaluate the effects of water-filtered Infrared-A radiation on patients suffering from hand osteoarthritis. The main questions it aims to answer are:

  • Does water-filtered Infrared-A radiation reduce pain and improve the function of finger joints over time?
  • Are patients satisfied with the treatment results when compared to those who were on a wait-list?
03

Conditions studied

  • Hand Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of finger polyarthritis (confirmed by a specialist, radiological findings available)
  • Local pain for more than 50% of the day in the past 3 months.
  • Subjective pain intensity of local pain in the last 24 hours on a VAS scale of 0 to 10 being >4.
  • No planned local treatment in the next 6 months.
  • No planned intra-articular injections within the next 6 months.
  • The patient must be able to understand the study explanations and appropriately follow the instructions of the investigating physician.

Exclusion criteria

Exclusion Criteria:

  • Chronic inflammatory joint diseases.
  • Poor general health.
  • Febrile diseases.
  • Fibromyalgia syndrome.
  • Psychotic disorders.
  • Severe comorbidities.
  • Acute unclear skin diseases.
  • Heat urticaria.
  • Painful diseases/diagnoses of the shoulder and/or arm.
  • Lymphatic vessel diseases (lymphedema, lymphangitis).
  • Porphyria.
  • Pain-associated diseases/diagnoses of the shoulder and/or arm.
  • Intra-articular injections or arthroscopies within the last 3 months.
  • Previous or planned surgical procedure on the affected joints in the last 8 weeks or in the upcoming 6 months.
  • Intake or application of photosensitizing drugs or extracts (e.g., porphyrins, tetracyclines, sulfonamides, psoralenes, St. John's wort).
  • Systemic medication with or .
  • Pain medication with opioid analgesics.
  • Known pregnancy.
  • Concurrent participation in another clinical trial.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Radiation

    Participants in the intervention group each receive a hyperthermia device for water-filtered Infrared-A radiation.

    Device: water-filtered Infrared-A radiation

  • No intervention
    Waiting list

    Participants in the control group initially receive no therapeutic intervention, but can receive it after the study's last visit for 3 months.

Interventions

  • Devicewater-filtered Infrared-A radiation

    The water-filtered Infrared-A radiation device is designed for self-administered home treatments. The regimen prescribes 30-minute sessions, five times weekly, spanning 12 weeks.

06

What researchers measure

Primary outcomes

  1. Pain in the finger joints on visual analogue scale

    Average pain in the finger joints over the last 7 days after 12 weeks compared to baseline on the Visual Analog Scale (VAS, 0-100mm) compared to the waiting list control group.

    Time frame: Baseline, 12 weeks

Secondary outcomes

  1. Hand Dynamometer

    Grip strength measured using a Hand Dynamometer (SAEHAN Corporation)

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  2. Disabilities of Arm, Shoulder and Hand (DASH) questionnaire

    Assessing full scale, range 0-100, higher score meaning a better outcome

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  3. Pain Self-Efficacy Questionnaire

    Assessing full scale, range 0-100, higher score meaning a better outcome

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  4. Hospital Anxiety and Depression Scale (HADS)

    Assessing full scale, range 0-100, higher score meaning a better outcome

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  5. Short Form (SF)-36 Health Survey (SF-36)

    Assessing full scale, range 0-100, higher score meaning a better outcome

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  6. Functional Index for Hand OsteoArthritis (FIHOA)

    Assessing functional impairment, scoring from 0 (no functional impairment) to 30 points (maximal impairment).

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  7. Tolerability of the intervention

    Monitoring tolerability of the intervention (5-point Likert scale, 1=very good tolerability to 5=very bad tolerability)

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

  8. Pain medication (number per day)

    Documenting changes in pain medication and pain medication on demand

    Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Feb 2025, 11 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 11 months is below that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2024
First posted
Mar 25, 2024
StartActual
Mar 26, 2024
Primary completionEst.
Feb 28, 2025
CompletionEst.
Dec 2025
Last update
Mar 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06329219
Responsible party
Andreas Michalsen (Principal Investigator, Charite University, Berlin, Germany) — Principal investigator
First posted
Mar 25, 2024
Start date
Mar 26, 2024
Primary completion
Feb 28, 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Mar 28, 2024

Study contacts

Miriam Rösner
Contact
naturheilkunde.studien@immanuel.de
+49 30 80505 682
Michael Jeitler, MD
Contact
naturheilkunde.studien@charite.de
+49 30 80505 693
Andreas Michalsen
principal investigator · Charite University, Berlin, Germany
Rainer Stange
principal investigator · Charite University, Berlin, Germany

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion